Login / Signup

Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice.

Wenhan YuSuddhasil MookherjeeVijender ChaitankarSuja HiriyannaJung-Woong KimMatthew BrooksYasaman AtaeijannatiXun SunLijin DongTiansen LiAnand SwaroopZhijian Wu
Published in: Nature communications (2017)
In retinitis pigmentosa, loss of cone photoreceptors leads to blindness, and preservation of cone function is a major therapeutic goal. However, cone loss is thought to occur as a secondary event resulting from degeneration of rod photoreceptors. Here we report a genome editing approach in which adeno-associated virus (AAV)-mediated CRISPR/Cas9 delivery to postmitotic photoreceptors is used to target the Nrl gene, encoding for Neural retina-specific leucine zipper protein, a rod fate determinant during photoreceptor development. Following Nrl disruption, rods gain partial features of cones and present with improved survival in the presence of mutations in rod-specific genes, consequently preventing secondary cone degeneration. In three different mouse models of retinal degeneration, the treatment substantially improves rod survival and preserves cone function. Our data suggest that CRISPR/Cas9-mediated NRL disruption in rods may be a promising treatment option for patients with retinitis pigmentosa.
Keyphrases